Johns Hopkins HIV Guide
Itraconazole
Itraconazole is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Following fungal infections in immunocompromised and non-immunocompromised patients:
- Aspergillosis: treatment-intolerant of or refractory to amphotericin B therapy
- Pulmonary and extrapulmonary blastomycosis
- Histoplasmosis, including chronic cavitary pulmonary disease and disseminated non-meningeal histoplasmosis
- Onychomycosis in non-immunocompromised patients (oral capsule):
- Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium)
- Onychomycosis of the fingernail due to dermatophytes (tinea unguium).
- Oropharyngeal and esophageal candidiasis (oral liquid)
- Neutropenic fever in patients with suspected fungal infection (oral liquid).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Coccidioidomycosis
- Cryptococcosis (fluconazole preferred)
- Penicilliosis
- Sporotrichosis
- Candida vaginitis
- Fluconazole-resistant esophageal candidiasis
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Following fungal infections in immunocompromised and non-immunocompromised patients:
- Aspergillosis: treatment-intolerant of or refractory to amphotericin B therapy
- Pulmonary and extrapulmonary blastomycosis
- Histoplasmosis, including chronic cavitary pulmonary disease and disseminated non-meningeal histoplasmosis
- Onychomycosis in non-immunocompromised patients (oral capsule):
- Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium)
- Onychomycosis of the fingernail due to dermatophytes (tinea unguium).
- Oropharyngeal and esophageal candidiasis (oral liquid)
- Neutropenic fever in patients with suspected fungal infection (oral liquid).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Coccidioidomycosis
- Cryptococcosis (fluconazole preferred)
- Penicilliosis
- Sporotrichosis
- Candida vaginitis
- Fluconazole-resistant esophageal candidiasis
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 3, 2021
Citation
Avdic, Edina. "Itraconazole." Johns Hopkins HIV Guide, 2021. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545112/all/Itraconazole.
Avdic E. Itraconazole. Johns Hopkins HIV Guide. 2021. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545112/all/Itraconazole. Accessed September 30, 2022.
Avdic, E. (2021). Itraconazole. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545112/all/Itraconazole
Avdic E. Itraconazole [Internet]. In: Johns Hopkins HIV Guide. ; 2021. [cited 2022 September 30]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545112/all/Itraconazole.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Itraconazole
ID - 545112
A1 - Avdic,Edina,Pharm.D.
Y1 - 2021/09/03/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545112/all/Itraconazole
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
